IntelligentMDx Obtains $3,000,000 New Round

  • Feed Type
  • Date
    6/29/2009
  • Company Name
    IntelligentMDx
  • Mailing Address
    19 Blackstone Street Cambridge, MA 02139
  • Company Description
    IntelligentMDx’s competitive advantage is in the production of superior performing tests with significantly faster time to market. Embedded in our approach is a bioinformatics process that uses mathematical algorithms to predict test failure and simulate real life conditions such as contamination or genetic mutations that would impact test functionality. IntelligentMDx’s current pipeline includes proprietary nucleic acid (DNA or RNA) tests for Real Time PCR. IntelligentMDx has a pipeline of single test (singleplex) and multi-test (multiplex), diagnostic solutions for a wide range of human diseases. We have built our product candidate portfolio through internal discovery and are advancing our product candidates through in-house R&D.
  • Website
    http://www.intelligentmdx.com/
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $3,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.